Outcome of Board Meeting
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TTK Healthcare reported FY2025-26 revenue of Rs.85,728 lakhs, up 7% from Rs.80,149 lakhs in the previous year. However, profit after tax declined 19.6% to Rs.6,568 lakhs (vs Rs.8,166 lakhs), primarily due to a Rs.758 lakh exceptional charge for labour code compliance (gratuity and compensated absences provisions), partially offset by a Rs.350 lakh GST refund. EPS fell to Rs.46.48 from Rs.57.79. The Board recommended a dividend of Rs.10 per share (100%) for shareholder approval at the 68th AGM on July 24, 2026. Statutory auditors PKF Sridhar & Santhanam issued an unmodified (clean) opinion. The Board also approved reappointment of Executive Chairman Mr. T T Raghunathan for another 5 years from November 2026, and appointed Geeyes & Co. as Cost Auditor for FY2026-27.
Revenue growth of 7% is positive but PAT decline of ~20% may concern investors. The clean audit opinion and dividend recommendation provide stability. The labour code exceptional charge is non-recurring but reduces bottom-line visibility.